Lumida
/GOCO
⌘K
Gohealth Inc

Gohealth Inc

GOCO
$0.31USD↑+5.14%+0.01 today

MARKET CAP

9.9M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$0 – $0

52W RANGE

$0
$7

AI Summary

Stalk
Sell NowHigh

GOCO remains in a Stage 4 decline with persistent lower highs and lower lows under declining EMAs. Relief rallies into the 9/20/50EMA and 50DMA quickly reject, and volume clusters on down moves confirm supply dominance. Short-term trend is down, with no exhaustion visible, making selling now into any bounce the optimal execution posture.

  • ↑Q4 ’24 revenue $389 M (+41% YoY) driven by operational efficiency
  • ↑CAC $501/submission (–27% YoY) reflects improved marketing strategies
  • ↓Q3 ’25 revenue $95 M down as focus shifted to quality over volume
Full analysis →

Buying

0

institutions

Selling

3

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

SELL0.000.00+-382.05 K-100.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL0.000.00+-42.84 K-100.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL0.000.00+-21.31 K-100.0%0.00%